Hunan Province Tumor Hospital
Long Zhang
This study aims to explore Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced Non-small Cell Lung Cancer in China
Non-small Cell Lung Cancer
Third-generation EGFR-TKI
EGFR-TKI
inclusion criteria Uncommon EGFR Mutant Advanced Non-small Cell Lung Cancer EGFR G719X, exon 20 insert mutation without any anti-cancer treatment history
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 800 participants |
| Official Title : | Survival Outcome of EGFR-TKI in Uncommon EGFR Mutant Advanced Non-small Cell Lung Cancer in China |
| Actual Study Start Date : | 2020-03-24 |
| Estimated Primary Completion Date : | 2025-12-24 |
| Estimated Study Completion Date : | 2027-12-24 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Long Zhang
Changsha, Hunan, China, 410013